Ledger.Open graph →
SEC Form D · Amendment · filed June 1, 2010

Revance Therapeutics, Inc

Offering
$33.4M
Sold
$33.4M
Exemption
—
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

People & firms on this filing (12)

Frank Kung · Newark, CADirectorL. D. Browne · Newark, CAExec · DirectorVicente Trelles · Newark, CADirectorRobert Byrnes · Newark, CADirectorJim Glasheen · Newark, CADirectorPhyllis Gardner · Newark, CADirectorJoel R. Beaudin · North River, NYExec · DirectorDan Beecroft · Boca Raton, FLDirectorBlake Beecroft · Boca Raton, FLDirectorToney Jennings · Austin, TXDirectorDaniel M. Teal · Austin, TXDirectorRichard Teal · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗